Dr Reddy's Plan B for Nexium generic in play; appetite for M&A too
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories appears to have progressed its Plan B - essentially a site transfer - to hang on to the generic Nexium (esomeprazole magnesium) opportunity.